Anti-CGRP antibody formulation
US11498959B2 · kind B2 · utility
0Cited by
7References
32Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 8, 2016 |
| Grant date | Nov 15, 2022 |
| Priority date | — |
| Expiry date | Sep 16, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical formulations for anti-CGRP antibodies, and methods of using the same, are provided which are useful as treatment for migraines, episodic headaches, chronic headaches, chronic cluster headaches, and episodic cluster headaches.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.